Meranda Parascandola

January 7, 2023

Chemistry, Manufacturing and Controls (CMC) for Cell & Gene Therapy (CGT) Products

Cell and gene therapies for treating multiple myeloma, such as CAR-T, have resulted in breakthrough health outcomes for patients. In the last decade, approval of cell and gene therapy (CGT) products has increased significantly. Multiple other products are in clinical development for solid tumors, genetic deficiencies, and infections that promise more effective […]
October 20, 2022

Why You Should Consider a Biologics Consulting Service

Biologics are complex molecular entities that require extensive planning and development strategies to control development costs, ensure compliance with regulations, and speed up a product to commercialization. Hiring a biologics consultant ensures you receive expert advice and support throughout the entire CMC development process. In this article, we will outline why you should consider a biologics consulting service and what benefits this will have for your company.
September 23, 2022

DS InPharmatics Announces Virtual Attendance of BIO Europe 2022, October 24-26

DSI’s recent acquisition by Paris-based Product Life Group (PLG) has granted the company options to further expand into the European market. We hold prior experience in Europe and ROW and are excited to explore more opportunities in these regions. The addition of PLG’s resources and support will allow the DS […]
August 26, 2022

DS InPharmatics Announces Attendance of Biopharm America 2022, September 28-29

Join the DSI team in Boston on September 28-29, 2022 at Biopharm America! We’re excited to be back in-person at BPA this year. For 2022, the conference is also providing two virtual days, October 4-5, 2022, for those unable to attend the conference in-person. We will be participating in the […]
May 19, 2022

DSI Announces Attendance of BIO International 2022, June 13-16

DSI announced today that it will be actively engaged in partnering meetings during the BIO International Convention. The 2022 BIO International Convention will transition to a virtual and in-person (optional) event format. This virtual gathering of the global biotech industry provides access to partners via BIO One-on-One Partnering and educational […]
February 25, 2022

DSI Announces Virtual Attendance of BIO Europe Spring 2022, March 28-31

DSI plans to attend the 2022 BIO Europe Spring conference virtually. Our new Director of Business Development, Ben Luts, will be joining the conference on behalf of DSI. To set up a meeting with Ben, contact him at bluts@dsinpharmatics.com or through the partnering site. Whether you’ve used our services in […]